Literature DB >> 16007151

Regulation of the stepwise proteolytic cleavage and secretion of PDGF-B by the proprotein convertases.

Geraldine Siegfried1, Ajoy Basak, Wendy Prichett-Pejic, Nathalie Scamuffa, Liming Ma, Suzanne Benjannet, John P Veinot, Fabien Calvo, Nabil Seidah, Abdel-Majid Khatib.   

Abstract

Platelet-derived growth factor-B (PDGF-B) is important for normal tissue growth and maintenance and its overexpression has been linked to several diseases, including cancer, fibrotic disease and atherosclerosis. Here, we show that synthesized as a precursor, proPDGF-B is converted to a mature form by proteolytic cleavage at two sites and its N-terminal cleavage is a prerequisite for processing at its C-terminus. The first cleavage occurs at residues RGRR81/, and the second cleavage close to residues ARPVT190, just before the C-terminal amino-acid sequence crucial for PDGF-B retention to cell surface. Cotransfection of a Furin-deficient cell line LoVo-C5 with proPDGF-B and different PC members revealed that Furin, PACE4, PC5, and PC7 are candidate proPDGF-B convertases. This finding is consistent with the in vitro digestions of a synthetic peptide mimicking the cleavage site of proPDGF-B. The processing of proPDGF-B is blocked by site-directed mutagenesis of the RGRR81/ sequence and by various PC inhibitors. Mutation of the PDGF-A and/or PDGF-B convertase sites, revealed that processing of both A and B chains is required for the formation of mature PDGF-B dimers and that the processing of the B chain controls the level of secreted and matrix-bound PDGF-BB forms. Our findings emphasize the importance of the convertase-directed processing of proPDGF-B at the RGRR81/ sequence for PDGF-B maturation and secretion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007151     DOI: 10.1038/sj.onc.1208838

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  Molecular Validation of PACE4 as a Target in Prostate Cancer.

Authors:  François D'Anjou; Sophie Routhier; Jean-Pierre Perreault; Alain Latil; David Bonnel; Isabelle Fournier; Michel Salzet; Robert Day
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

2.  Proprotein convertase subtilisin/kexin type 7 (PCSK7) is essential for the zebrafish development and bioavailability of transforming growth factor β1a (TGFβ1a).

Authors:  Hannu Turpeinen; Anna Oksanen; Virpi Kivinen; Sampo Kukkurainen; Annemari Uusimäki; Mika Rämet; Mataleena Parikka; Vesa P Hytönen; Matti Nykter; Marko Pesu
Journal:  J Biol Chem       Date:  2013-10-31       Impact factor: 5.157

3.  The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer.

Authors:  Abdel-Majid Khatib; John W M Creemers; Zongsheng He; Lieven Thorrez; Geraldine Siegfried; Sandra Meulemans; Serge Evrard; Sabine Tejpar
Journal:  Oncogene       Date:  2020-03-06       Impact factor: 9.867

4.  Proprotein convertases play an important role in regulating PKGI endoproteolytic cleavage and nuclear transport.

Authors:  Shin Kato; Ruiguang Zhang; Jesse D Roberts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-05-17       Impact factor: 5.464

5.  Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth.

Authors:  Daniel E Bassi; Jirong Zhang; Catherine Renner; Andres J Klein-Szanto
Journal:  Mol Carcinog       Date:  2016-09-22       Impact factor: 4.784

6.  Internalization of proprotein convertase PC7 from plasma membrane is mediated by a novel motif.

Authors:  Jeroen Declercq; Sandra Meulemans; Evelyn Plets; John W M Creemers
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

7.  Regulation of HIF-1 alpha by the proprotein convertases furin and PC7 in human squamous carcinoma cells.

Authors:  Jian Fu; Jirong Zhang; Yulan Gong; Courtney Lyons Testa; Andres J Klein-Szanto
Journal:  Mol Carcinog       Date:  2014-01-16       Impact factor: 4.784

8.  In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate.

Authors:  Rachid Essalmani; Ahmed Zaid; Jadwiga Marcinkiewicz; Ann Chamberland; Antonella Pasquato; Nabil G Seidah; Annik Prat
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

9.  ELA/APELA precursor cleaved by furin displays tumor suppressor function in renal cell carcinoma through mTORC1 activation.

Authors:  Fabienne Soulet; Clement Bodineau; Katarzyna B Hooks; Jean Descarpentrie; Isabel Alves; Marielle Dubreuil; Amandine Mouchard; Malaurie Eugenie; Jean-Luc Hoepffner; Jose J López; Juan A Rosado; Isabelle Soubeyran; Mercedes Tomé; Raúl V Durán; Macha Nikolski; Bruno O Villoutreix; Serge Evrard; Geraldine Siegfried; Abdel-Majid Khatib
Journal:  JCI Insight       Date:  2020-07-23

10.  A novel enediynyl peptide inhibitor of furin that blocks processing of proPDGF-A, B and proVEGF-C.

Authors:  Ajoy Basak; Abdel-Majid Khatib; Dayani Mohottalage; Sarmistha Basak; Maria Kolajova; Subhendu Sekhar Bag; Amit Basak
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.